1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Dynamic methylation and expression of alternative promoters for oestrogen receptor alpha in cell line models of fulvestrant resistance
Albrecht, Juliane LU
; Müller, Mirjam
LU
; Hafstað, Völundur
LU
; Kaminska, Kamila
LU
; Vallon-Christersson, Johan
LU
; Honeth, Gabriella
LU
and Persson, Helena
LU
(2025)
In Molecular Oncology
19(1).
p.204-224
- Contribution to journal › Article
- 2024
-
Mark
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Lauss, Martin LU ; Phung, Bengt LU ; Borch, Troels Holz ; Harbst, Katja LU
; Kaminska, Kamila
LU
; Ebbesson, Anna
LU
; Hedenfalk, Ingrid
LU
; Yuan, Joan
LU
; Nielsen, Kari
LU
and Ingvar, Christian
LU
, et al.
(2024)
In Nature Communications
15(1).
- Contribution to journal › Article
- 2021
-
Mark
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
Kaminska, Kamila LU ; Akrap, Nina LU ; Staaf, Johan LU
; Alves, Carla L
; Ehinger, Anna
LU
; Ebbesson, Anna
LU
; Hedenfalk, Ingrid
LU
; Beumers, Lukas
LU
; Veerla, Srinivas
LU
and Harbst, Katja
LU
, et al.
(2021)
In Breast cancer research : BCR
23(1).
p.26-26
- Contribution to journal › Article
-
Mark
Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
- Contribution to journal › Article